Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression

S Li, D Yang, X Zhou, L Chen, L Liu… - CNS Neuroscience …, 2024 - Wiley Online Library
Background The comorbidity between diabetes mellitus and depression was revealed, and
diabetes mellitus increased the prevalence of depressive disorder, which ranked 13th in the …

Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: a case-control study

M Sohan, MMAS Qusar, M Shahriar, SMA Islam… - Plos one, 2023 - journals.plos.org
Background Major depressive disorder (MDD) is a heterogeneous mental disorder having a
very diverse course and causing a significant changes in daily life. Though the exact …

Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results

J Nayem, R Sarker, ASM Roknuzzaman, MMAS Qusar… - Plos one, 2023 - journals.plos.org
Background Major Depressive Disorder (MDD) is a debilitating mental health condition with
complex etiology, and recent research has focused on pro-inflammatory cytokines and …

Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: A case–control study

L Salsabil, M Shahriar, SMA Islam… - Journal of …, 2023 - journals.sagepub.com
Objective There is a lack of established biological, psychological, social, and digital markers
for the prediction, identification, and stratification of patients with major depressive disorder …

Elevated serum IL-2 levels are Associated with Major Depressive disorder: a case-control study

FI Suhee, M Shahriar, SMA Islam… - Clinical …, 2023 - journals.sagepub.com
Objectives: Numerous earlier studies have stated an association between major depressive
disorder (MDD) and altered expression of inflammatory process. However, it still needs to …

Higher serum interleukin‐12 levels are associated with the pathophysiology of major depressive disorder: A case‐control study results

Z Nahar, N Sal‐Sabil, M Sohan… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aims Major depressive disorder (MDD) is the fourth biggest health‐
related concern that dramatically impacts individuals' mental and physical health. Alteration …

Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative …

Z Nahar, DT Nowshin, ASM Roknuzzaman, M Sohan… - BMC psychiatry, 2024 - Springer
Background Major depressive disorder (MDD) is a debilitating health condition that has
significant morbidity and mortality rates. Depression can be caused due to social, biological …

Metabolomic disorders: Confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior

LA Pan, AM Segreti, J Wrobleski, A Shaw… - Psychological …, 2023 - cambridge.org
BackgroundRefractory depression is a devastating condition with significant morbidity,
mortality, and societal cost. Approximately 15% of patients with major depressive disorder …

Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients

O Hursitoglu, EB Kurutas, R Strawbridge, E Oner… - Progress in Neuro …, 2023 - Elsevier
Introduction Biological factors are known to be important in understanding the pathogenesis
of Major Depressive Disorder (MDD). Oxidative stress and neuroinflammation pathways are …

Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder

N Sarmin, ASM Roknuzzaman, TZ Mouree… - Scientific Reports, 2024 - nature.com
Recently, scientists have focused on pro-inflammatory cytokines and immunological
dysregulation in major depressive disorder (MDD). Some research suggests pro …